COVID-19 Impact on Global OAB Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 99 pages | ID: CC650544EADCEN
QYResearch

Abstracts

This report focuses on the global OAB Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the OAB Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Astellas Pharma
• Allergan
• Pfizer
• Teva (Activas)
• Johnson & Johnson

Market segment by Type, the product can be split into

• Anticholinergics
• Mirabegron
• Botox

Market segment by Application, split into

• Idiopathic Overactive Bladder
• Neurogenic Overactive Bladder

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global OAB Treatment status, future forecast, growth opportunity, key market and key players.
• To present the OAB Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of OAB Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by OAB Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global OAB Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Anticholinergics
  1.4.3 Mirabegron
  1.4.4 Botox
1.5 Market by Application
  1.5.1 Global OAB Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Idiopathic Overactive Bladder
  1.5.3 Neurogenic Overactive Bladder
1.6 Coronavirus Disease 2019 (Covid-19): OAB Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the OAB Treatment Industry
    1.6.1.1 OAB Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and OAB Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for OAB Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 OAB Treatment Market Perspective (2015-2026)
2.2 OAB Treatment Growth Trends by Regions
  2.2.1 OAB Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 OAB Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 OAB Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 OAB Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key OAB Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top OAB Treatment Players by Market Size
  3.1.1 Global Top OAB Treatment Players by Revenue (2015-2020)
  3.1.2 Global OAB Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global OAB Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global OAB Treatment Market Concentration Ratio
  3.2.1 Global OAB Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by OAB Treatment Revenue in 2019
3.3 OAB Treatment Key Players Head office and Area Served
3.4 Key Players OAB Treatment Product Solution and Service
3.5 Date of Enter into OAB Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global OAB Treatment Historic Market Size by Type (2015-2020)
4.2 Global OAB Treatment Forecasted Market Size by Type (2021-2026)

5 OAB TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global OAB Treatment Market Size by Application (2015-2020)
5.2 Global OAB Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America OAB Treatment Market Size (2015-2020)
6.2 OAB Treatment Key Players in North America (2019-2020)
6.3 North America OAB Treatment Market Size by Type (2015-2020)
6.4 North America OAB Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe OAB Treatment Market Size (2015-2020)
7.2 OAB Treatment Key Players in Europe (2019-2020)
7.3 Europe OAB Treatment Market Size by Type (2015-2020)
7.4 Europe OAB Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China OAB Treatment Market Size (2015-2020)
8.2 OAB Treatment Key Players in China (2019-2020)
8.3 China OAB Treatment Market Size by Type (2015-2020)
8.4 China OAB Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan OAB Treatment Market Size (2015-2020)
9.2 OAB Treatment Key Players in Japan (2019-2020)
9.3 Japan OAB Treatment Market Size by Type (2015-2020)
9.4 Japan OAB Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia OAB Treatment Market Size (2015-2020)
10.2 OAB Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia OAB Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia OAB Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India OAB Treatment Market Size (2015-2020)
11.2 OAB Treatment Key Players in India (2019-2020)
11.3 India OAB Treatment Market Size by Type (2015-2020)
11.4 India OAB Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America OAB Treatment Market Size (2015-2020)
12.2 OAB Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America OAB Treatment Market Size by Type (2015-2020)
12.4 Central & South America OAB Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Astellas Pharma
  13.1.1 Astellas Pharma Company Details
  13.1.2 Astellas Pharma Business Overview and Its Total Revenue
  13.1.3 Astellas Pharma OAB Treatment Introduction
  13.1.4 Astellas Pharma Revenue in OAB Treatment Business (2015-2020))
  13.1.5 Astellas Pharma Recent Development
13.2 Allergan
  13.2.1 Allergan Company Details
  13.2.2 Allergan Business Overview and Its Total Revenue
  13.2.3 Allergan OAB Treatment Introduction
  13.2.4 Allergan Revenue in OAB Treatment Business (2015-2020)
  13.2.5 Allergan Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer OAB Treatment Introduction
  13.3.4 Pfizer Revenue in OAB Treatment Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Teva (Activas)
  13.4.1 Teva (Activas) Company Details
  13.4.2 Teva (Activas) Business Overview and Its Total Revenue
  13.4.3 Teva (Activas) OAB Treatment Introduction
  13.4.4 Teva (Activas) Revenue in OAB Treatment Business (2015-2020)
  13.4.5 Teva (Activas) Recent Development
13.5 Johnson & Johnson
  13.5.1 Johnson & Johnson Company Details
  13.5.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.5.3 Johnson & Johnson OAB Treatment Introduction
  13.5.4 Johnson & Johnson Revenue in OAB Treatment Business (2015-2020)
  13.5.5 Johnson & Johnson Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. OAB Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by OAB Treatment Revenue
Table 3. Ranking of Global Top OAB Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global OAB Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticholinergics
Table 6. Key Players of Mirabegron
Table 7. Key Players of Botox
Table 8. COVID-19 Impact Global Market: (Four OAB Treatment Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for OAB Treatment Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for OAB Treatment Players to Combat Covid-19 Impact
Table 13. Global OAB Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global OAB Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global OAB Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global OAB Treatment Market Share by Regions (2015-2020)
Table 17. Global OAB Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global OAB Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. OAB Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key OAB Treatment Players
Table 24. Global OAB Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global OAB Treatment Market Share by Players (2015-2020)
Table 26. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OAB Treatment as of 2019)
Table 27. Global OAB Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players OAB Treatment Product Solution and Service
Table 30. Date of Enter into OAB Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global OAB Treatment Market Size Share by Type (2015-2020)
Table 34. Global OAB Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global OAB Treatment Market Size Share by Application (2015-2020)
Table 36. Global OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global OAB Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players OAB Treatment Market Share (2019-2020)
Table 40. North America OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America OAB Treatment Market Share by Type (2015-2020)
Table 42. North America OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America OAB Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players OAB Treatment Market Share (2019-2020)
Table 46. Europe OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe OAB Treatment Market Share by Type (2015-2020)
Table 48. Europe OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe OAB Treatment Market Share by Application (2015-2020)
Table 50. China Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players OAB Treatment Market Share (2019-2020)
Table 52. China OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China OAB Treatment Market Share by Type (2015-2020)
Table 54. China OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China OAB Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players OAB Treatment Market Share (2019-2020)
Table 58. Japan OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan OAB Treatment Market Share by Type (2015-2020)
Table 60. Japan OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan OAB Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players OAB Treatment Market Share (2019-2020)
Table 64. Southeast Asia OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia OAB Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia OAB Treatment Market Share by Application (2015-2020)
Table 68. India Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players OAB Treatment Market Share (2019-2020)
Table 70. India OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India OAB Treatment Market Share by Type (2015-2020)
Table 72. India OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India OAB Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players OAB Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players OAB Treatment Market Share (2019-2020)
Table 76. Central & South America OAB Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America OAB Treatment Market Share by Type (2015-2020)
Table 78. Central & South America OAB Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America OAB Treatment Market Share by Application (2015-2020)
Table 80. Astellas Pharma Company Details
Table 81. Astellas Pharma Business Overview
Table 82. Astellas Pharma Product
Table 83. Astellas Pharma Revenue in OAB Treatment Business (2015-2020) (Million US$)
Table 84. Astellas Pharma Recent Development
Table 85. Allergan Company Details
Table 86. Allergan Business Overview
Table 87. Allergan Product
Table 88. Allergan Revenue in OAB Treatment Business (2015-2020) (Million US$)
Table 89. Allergan Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in OAB Treatment Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Teva (Activas) Company Details
Table 96. Teva (Activas) Business Overview
Table 97. Teva (Activas) Product
Table 98. Teva (Activas) Revenue in OAB Treatment Business (2015-2020) (Million US$)
Table 99. Teva (Activas) Recent Development
Table 100. Johnson & Johnson Company Details
Table 101. Johnson & Johnson Business Overview
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Revenue in OAB Treatment Business (2015-2020) (Million US$)
Table 104. Johnson & Johnson Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global OAB Treatment Market Share by Type: 2020 VS 2026
Figure 2. Anticholinergics Features
Figure 3. Mirabegron Features
Figure 4. Botox Features
Figure 5. Global OAB Treatment Market Share by Application: 2020 VS 2026
Figure 6. Idiopathic Overactive Bladder Case Studies
Figure 7. Neurogenic Overactive Bladder Case Studies
Figure 8. OAB Treatment Report Years Considered
Figure 9. Global OAB Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global OAB Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global OAB Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global OAB Treatment Market Share by Players in 2019
Figure 14. Global Top OAB Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in OAB Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by OAB Treatment Revenue in 2019
Figure 16. North America OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America OAB Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Astellas Pharma Revenue Growth Rate in OAB Treatment Business (2015-2020)
Figure 25. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Allergan Revenue Growth Rate in OAB Treatment Business (2015-2020)
Figure 27. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Pfizer Revenue Growth Rate in OAB Treatment Business (2015-2020)
Figure 29. Teva (Activas) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Teva (Activas) Revenue Growth Rate in OAB Treatment Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in OAB Treatment Business (2015-2020)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed